Table 1.
Annotated target location | Supportive | Uncertain | Sum | |||
---|---|---|---|---|---|---|
N | % | N | % | N | % | |
Cellular | 15 | 27 | 41 | 73 | 56 | 36 |
Extracellular | 9 | 34 | 17 | 65 | 26 | 16 |
Plasma (MS) | 46 | 61 | 29 | 39 | 75 | 48 |
Total | 70 | 45 | 87 | 55 | 157* | 100 |
*Total number of antibodies used in the study, including 4 antibodies used only in the phase of optimization, for which a z-score was not calculated. These 4 antibodies were anyway classified as supportive if they immuno-precipitate and enriched their target.